DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma
Authors
Keywords
-
Journal
Epigenomics
Volume 7, Issue 6, Pages 985-1001
Publisher
Future Medicine Ltd
Online
2015-09-30
DOI
10.2217/epi.15.57
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers
- (2015) Xabier Agirre et al. GENOME RESEARCH
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Global Epigenetic Regulation of MicroRNAs in Multiple Myeloma
- (2014) Wenjing Zhang et al. PLoS One
- The role of epigenetics in the biology of multiple myeloma
- (2014) K Dimopoulos et al. Blood Cancer Journal
- Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients
- (2014) B A Walker et al. Blood Cancer Journal
- The DAPK family: a structure–function analysis
- (2013) Ruth Shiloh et al. APOPTOSIS
- Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma
- (2013) M. F. Kaiser et al. BLOOD
- Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients
- (2013) A. Dufour et al. BLOOD
- Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma
- (2013) S. Van Wier et al. HAEMATOLOGICA
- Myeloma Is Characterized by Stage-Specific Alterations in DNA Methylation That Occur Early during Myelomagenesis
- (2013) C. J. Heuck et al. JOURNAL OF IMMUNOLOGY
- New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
- (2013) E M Ocio et al. LEUKEMIA
- IMWG consensus on risk stratification in multiple myeloma
- (2013) W J Chng et al. LEUKEMIA
- Signaling through cyclin D-dependent kinases
- (2013) Y J Choi et al. ONCOGENE
- Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1
- (2013) P Wang et al. ONCOGENE
- Concise Drug Review: Azacitidine and Decitabine
- (2013) E. J. B. Derissen et al. ONCOLOGIST
- DNA methylation of microRNA genes in multiple myeloma
- (2012) K. Y. Wong et al. CARCINOGENESIS
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Specificity of Dnmt1 for Methylation of Hemimethylated CpG Sites Resides in Its Catalytic Domain
- (2012) Pavel Bashtrykov et al. CHEMISTRY & BIOLOGY
- Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
- (2012) Pasquale Sansone et al. JOURNAL OF CLINICAL ONCOLOGY
- Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
- (2012) C Fernández de Larrea et al. LEUKEMIA
- Methylation-mediated repression of microRNA 129-2 enhances oncogenic SOX4 expression in HCC
- (2012) Xiangmei Chen et al. LIVER INTERNATIONAL
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- Long non-coding RNAs and cancer: a new frontier of translational research?
- (2012) R Spizzo et al. ONCOGENE
- Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myeloma
- (2012) V Grossmann et al. Blood Cancer Journal
- Epigenetic inactivation of the MIR34B/C in multiple myeloma
- (2011) K. Y. Wong et al. BLOOD
- Epigenetic silencing of MIR203 in multiple myeloma
- (2011) Kwan-Yeung Wong et al. BRITISH JOURNAL OF HAEMATOLOGY
- Epigenetic Silencing of MicroRNA-203 Dysregulates ABL1 Expression and Drives Helicobacter-Associated Gastric Lymphomagenesis
- (2011) V. J. Craig et al. CANCER RESEARCH
- CpG island methylation status of miRNAs in esophageal squamous cell carcinoma
- (2011) Xuedan Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Epigenetic inactivation of the hsa-miR-203 in haematological malignancies
- (2011) Chor Sang Chim et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
- (2011) Chor Sang Chim et al. Journal of Translational Medicine
- MicroRNA signatures characterize multiple myeloma patients
- (2011) S L Corthals et al. LEUKEMIA
- The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
- (2011) S K Martin et al. LEUKEMIA
- A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
- (2011) K D Boyd et al. LEUKEMIA
- Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer
- (2011) Norimitsu Tanaka et al. LUNG CANCER
- Diagnosis of Smoldering Multiple Myeloma
- (2011) S. Vincent Rajkumar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies
- (2011) Kwan Yeung Wong et al. PLoS One
- Could DNA methylation become a useful measure for multiple myeloma prognoses?
- (2011) Brian A Walker et al. Expert Review of Hematology
- DNA methylation of tumor suppressor miRNA genes: a lesson from themiR-34family
- (2011) Kwan Yeung Wong et al. Epigenomics
- Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer
- (2010) Ruizhe Shen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interplay between microRNAs and the epigenetic machinery: An intricate network
- (2010) Marilena V. Iorio et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value
- (2010) B. A. Walker et al. BLOOD
- Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma
- (2010) B. A. Walker et al. BLOOD
- Hematopoietic stem cell transplantation for multiple myeloma beyond 2010
- (2010) J. Blade et al. BLOOD
- Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
- (2010) Flavia Pichiorri et al. CANCER CELL
- Epigenetic inactivation of the miR-34a in hematological malignancies
- (2010) C.S. Chim et al. CARCINOGENESIS
- miR-129 regulates cell proliferation by downregulating Cdk6 expression
- (2010) Junjie Wu et al. CELL CYCLE
- Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
- (2010) D. C. Corney et al. CLINICAL CANCER RESEARCH
- Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1
- (2010) Jinfeng Huang et al. HEPATOLOGY
- Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients
- (2010) Chor Chim Journal of Translational Medicine
- Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
- (2010) R A Kyle et al. LEUKEMIA
- Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer
- (2010) Saskia M Wilting et al. Molecular Cancer
- DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer
- (2010) Amy Sharma et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Orphan CpG Islands Identify Numerous Conserved Promoters in the Mammalian Genome
- (2010) Robert S. Illingworth et al. PLoS Genetics
- MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
- (2009) R. Garzon et al. BLOOD
- Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial
- (2009) T. Zenz et al. BLOOD
- Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma
- (2009) E. Jost et al. CANCER LETTERS
- Epigenetic Repression of microRNA-129-2 Leads to Overexpression of SOX4 Oncogene in Endometrial Cancer
- (2009) Y.-W. Huang et al. CANCER RESEARCH
- Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
- (2009) L. Dyrskjot et al. CANCER RESEARCH
- Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia
- (2009) X. Agirre et al. CANCER RESEARCH
- miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
- (2009) Elena Gallardo et al. CARCINOGENESIS
- miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma
- (2009) Mayuko Furuta et al. CARCINOGENESIS
- MicroRNA Control in the Immune System: Basic Principles
- (2009) Changchun Xiao et al. CELL
- The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia
- (2009) Eleftheria Hatzimichael et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Epigenetic regulation of microRNA expression in colorectal cancer
- (2009) Eva Bandres et al. INTERNATIONAL JOURNAL OF CANCER
- Methylation status of nine tumor suppressor genes in multiple myeloma
- (2009) Esteban Braggio et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
- (2009) R Fonseca et al. LEUKEMIA
- miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities
- (2009) M Mraz et al. LEUKEMIA
- Long non-coding RNAs: insights into functions
- (2009) Tim R. Mercer et al. NATURE REVIEWS GENETICS
- Linking DNA methylation and histone modification: patterns and paradigms
- (2009) Howard Cedar et al. NATURE REVIEWS GENETICS
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
- (2008) Joachim Silber et al. BMC Medicine
- SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response
- (2008) S Cheetham et al. BRITISH JOURNAL OF CANCER
- Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression
- (2008) María J. Bueno et al. CANCER CELL
- Epigenetic Silencing of MicroRNA-34b/c and B-Cell Translocation Gene 4 Is Associated with CpG Island Methylation in Colorectal Cancer
- (2008) M. Toyota et al. CANCER RESEARCH
- 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation
- (2008) M K Dijkstra et al. LEUKEMIA
- Clinical and biological significance of RAS mutations in multiple myeloma
- (2008) W J Chng et al. LEUKEMIA
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
- (2008) Witold Filipowicz et al. NATURE REVIEWS GENETICS
- A microRNA DNA methylation signature for human cancer metastasis
- (2008) A. Lujambio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-34a repression of SIRT1 regulates apoptosis
- (2008) M. Yamakuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started